Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph + chronic myeloid leukemia-Reference-Cited by-同舟云学术

Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph + chronic myeloid leukemia

Published:2018-01 Issue: Volume:57 Page:50-59.e6
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Willmann Michael,Sadovnik Irina,Eisenwort Gregor,Entner Martin,Bernthaler Tina,Stefanzl Gabriele,Hadzijusufovic Emir,Berger Daniela,Herrmann Harald,Hoermann Gregor,Valent Peter,Rülicke Thomas

Funder

Austrian Science Fund

Medical University of Vienna

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference54 articles.

1. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining;Rowley;Nature,1973

2. The biology of chronic myeloid leukemia;Faderl;N Engl J Med,1999

3. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

4. Chronic myeloid leukaemia as a model of disease evolution in human cancer;Melo;Nat Rev Cancer,2007

5. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome;Daley;Science,1990

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel targeted therapies in chronic myeloid leukemia;Pharmaceutical Science Advances;2024-09

2. Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors;Expert Opinion on Pharmacotherapy;2024-01-22

3. How to improve treatment‐free remission eligibility in chronic myeloid leukaemia?;British Journal of Haematology;2023-12-26

4. The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities;Current Hematologic Malignancy Reports;2023-02-13

5. In the Pipeline: Emerging Therapy for CML;Pathogenesis and Treatment of Leukemia;2023